NCT01515748 - Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer | Biotech Hunter

Enrollment

530

Participants

Timeline

Start Date

December 30, 2011

Primary Completion Date

January 21, 2019

Study Completion Date

December 13, 2021

Conditions

Gastric Cancer

Interventions

DRUG

Docetaxel (XRP6976)

Pharmaceutical form:solution for infusion Route of administration: intravenous

DRUG

Oxaliplatin (SR96669)

Pharmaceutical form:solution for infusion Route of administration: intravenous

DRUG

S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil)

Pharmaceutical form:Tablet Route of administration: Oral

Trial Locations (1)

Administrative Office, Seoul